Company / PP&E (Net)
Pediatrix Medical Group PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$39.2M
FY2025
5-year range
$39.2M / $75.6M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#100 of 132
Health Care
What the data says
Pediatrix Medical Group's pp&e (net) of $39M is lower than 76% of companies in the Health Care sector (FY2025). PP&E (Net) has fluctuated over the past 10 years, ranging from $39M in FY2024 to $124M in FY2017.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of -12.5%.
Declined from $76M to $39M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -18.8%
- 5-Year CAGR
- -12.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 132This company $39.2M Sector average $1.4B
▼
-97.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -12.5%, indicating a declining trend.
- In FY2025, pp&e (net) increased 0.0% year-over-year.
- Ranks #100 out of 132 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.65 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.2M | +0.0% |
| FY2024 | $39.2M | -48.2% |
| FY2023 | $75.6M | +3.2% |
| FY2022 | $73.3M | +4.5% |
| FY2021 | $70.2M | -7.9% |
| FY2020 | $76.2M | +4.8% |
| FY2019 | $72.7M | -19.6% |
| FY2018 | $90.4M | -26.8% |
| FY2017 | $123.5M | +19.9% |
| FY2016 | $103.1M | +23.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026